China National Medicines Corporation Ltd. (SHA: 600511)

Market Cap	21.92B
Revenue (ttm)	50.31B
Net Income (ttm)	2.16B
Shares Out	754.50M
EPS (ttm)	2.87
PE Ratio	10.14
Forward PE	8.78
Dividend	0.85 (2.94%)
Ex-Dividend Date	Jun 13, 2024

Volume	4,244,704
Open	29.02
Previous Close	29.05
Day's Range	28.80 - 29.27
52-Week Range	26.58 - 37.80
Beta	0.40
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 21, 2024

About China National Medicines Corporation

China National Medicines Corporation Ltd., together with its subsidiaries, distributes pharmaceutical products in China. The company also manufactures and sells new drugs and finished drugs; sells Chinese patent medicines and western medicines, and medical equipment; and offers warehousing and import and export agency services. It serves hospitals, retail pharmacies, and medical institutions. The company was founded in 1999 and is based in Beijing, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 3,138
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600511

Financial Performance

In 2023, 600511's revenue was 49.70 billion, an increase of 9.23% compared to the previous year's 45.50 billion. Earnings were 2.15 billion, an increase of 9.26%.